The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates

Vaccine

Volumn 31, Issue 42, 2013, Pages 4744-4748

  Waye, Arianna ^a   Jacobs, Philip ^a,b   Tan, Ben ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Effectiveness; Herd immunity; Hospitalization rates; Vaccine; Varicella

Indexed keywords

CHICKENPOX VACCINE; PRIORIX TETRA; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHICKENPOX; CHILD HEALTH CARE; CHILD HOSPITALIZATION; HEALTH CARE DISPARITY; HEALTH SURVEY; HERD IMMUNITY; HUMAN; IMMUNIZATION; INFANT; INFANT DISEASE; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; POSTVARICELLA ENCEPHALITIS; PRIORITY JOURNAL; VIRUS ENCEPHALITIS; VIRUS PNEUMONIA;

EFFECTIVENESS; HERD IMMUNITY; HOSPITALIZATION RATES; VACCINE; VARICELLA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANADA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; VACCINATION; YOUNG ADULT;

EID: 84884204736     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.022     Document Type: Article

References (27)

1. National Advisory Committee on Immunization National Advisory Committee on Immunization (NACI) update on varicella. Can Commun Dis Rep 2004, 30:1-26.
2. Public Health Agency of Canada Incidence by age group: chicken pox 2006, Ref Type: Data File.
3. National Advisory Committee on Immunization Statement on recommended use of varicella virus vaccine. Can Commun Dis Rep 1999, 25:1-16.
4. Keelan J., Lazar H., Wilson K. The national immunization strategy. Can J Public Health 2008, 99(5):376-379.
5. Brisson M., Edmunds W. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making 2003, 76-82.
6. Manski C. Vaccination with partial knowledge of external effectiveness. PNAS 2010, 107(9):3953-3960.
7. Giraldo J., Palacio H. Deterministic SIR models applied to varicella outbreaks. Epidemiol Infect 2008, 136(5):679-687.
8. Marin M., Watson T., Chaves S., et al. Varicella among adults: data from an active surveillance project. J Infect Dis 2008, 197(Suppl. 2):S94-S100.
9. Coudeville L., Brunot A., Szucs T., Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health 2005, 8(3):209-222.
10. Reynolds M., Watson B., Plott-Adams K., et al. Epidemiology of varicella hospitalizations in the US, 1995-2005. J Infect Dis 2008, 197(Suppl. 2):S120-S126.
11. Thiry N., Beutels P., Van Damme P., Van Doorslaer E. Economic evaluations of varicella vaccination programmes. Pharmacoeconomics 2003, 21(1):13-38.
12. Pozza F., Piovesan C., Russo F., Bella A., Pezzotti P., Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine 2011, 29:9480-9487.
13. Quian J., Ruttimann R., Romero C., Dall'Orso P., Cerisola A., Breuer T., et al. Impact of universal varicella vaccination on 1-year-olds in uruguay. Arch Dis Child 2008, 93(10):845-850.
14. Marhsall H., McIntyre P., Richmond P., Buttery J., Royle J., Gold M., et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2013, 32(5):530-537.
15. Tseng H., Tan H., Chang C. Use of national health insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan. Vaccine 2006, 24(25):5341-5348.
16. Lopez A., Zhang J., Brown C., Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: The 1-dose varicella vaccination era. Pediatrics 2011, 127:238-245.
17. Nguyen H., Jurmaan A., Seward J. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New Engl J Med 2005, 352(5):450-458.
18. Tan B., Bettinger J., McConnell A., Scheifele D., Halperin S., Vaudry W., et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in impact centers Canada, 2000-2008. Pediatr Infect Dis J 2012, 31(9):956-963.
19. Kwong J., Tanuseputro P., Zagorski B., Moineddin R., Chan K. Impact of varicella vaccination on health care outcomes in ontario canada: effect of a publically funded program?. Vaccine 2008, 26:6006-6012.
20. Canadian Institute of Health Information Varicella related hospitalizations 1994-2010 2012, Ref Type: Data File.
21. Omer S., Salmon D., Orenstein W., deHart P., Halsey N. Vaccine refusal mandatory immunization, and the risks of vaccine preventable diseases. New Engl J Med 2009, 30(19):1981-1988.
22. Naylor C., Slaughter P. Cardiovascular health and services in Ontario: an ICES atlas 1999, Institute for Clinical Evaluative Sciences, Toronto, Ontario.
23. Statistics Canada. Table 051-0001: estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual (persons) 2013.
24. National Advisory Committee on Immunization Varicella vaccination two-dose recommendations. Can Commun Dis Rep 2010, 36:1-22.
25. Zhou F., Harpaz R., Jumaan A., Winston C., Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005, 294:797-802.
26. Davis M., Patel M., Chem B., Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004, 114(3):786-792.
27. DeWals P., Blackburn M., Guay M., Bravo G., Blanchette D., Douville-Fradet M. Burden of chickenpox on famiolies: a study in Quebec Canada. J Infect Dis 2001, 12(1):27-32.